SCHEDULE 13G/A: Darwin Global Management and Affiliates Disclose 8.5% Passive Stake in INSMED Inc.

Darwin Global Management, Ltd., Dr. Abhishek Trehan, and Darwin Global Master Fund, Ltd. have collectively reported a passive beneficial ownership of 8.5% of INSMED Inc.'s common stock as of March 31, 2025.

Summary

• Darwin Global Management, Ltd., Dr. Abhishek Trehan, and Darwin Global Master Fund, Ltd. (collectively, "Reporting Persons") have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in INSMED Inc.
• As of March 31, 2025, Darwin Global Management, Ltd. and Dr. Abhishek Trehan beneficially own an aggregate of 15,397,975 shares of INSMED Inc. common stock.
• This represents 8.5% of INSMED Inc.'s outstanding common stock.
• Darwin Global Master Fund, Ltd. directly holds 13,547,617 shares, representing 7.5% of the class.
• The percentage is calculated based on 180,999,350 shares of common stock outstanding as of February 14, 2025, as reported in INSMED Inc.'s Form 10-K filed on February 20, 2025.
• The Reporting Persons explicitly state that the securities were not acquired or held for the purpose of changing or influencing control of INSMED Inc.

Sentiment

Score: 6

Explanation: The filing indicates a significant passive investment by an institutional group, which can be viewed as a vote of confidence, but it does not contain operational or financial performance data to assess overall sentiment.

Positives

• A significant institutional investor, Darwin Global Management, Ltd. and its affiliates, has disclosed a substantial passive stake of 8.5% in INSMED Inc., which can be interpreted as a vote of confidence in the company's long-term prospects.

Negatives

• No negative information regarding INSMED Inc.'s operations or financial health was disclosed in this passive ownership filing.

Future Outlook

This filing, a Schedule 13G, pertains solely to beneficial ownership disclosure and does not contain any forward-looking statements or guidance regarding INSMED Inc.'s future outlook.

Industry Context

This Schedule 13G filing primarily concerns a change in beneficial ownership by a specific investment group and does not provide direct insights into broader industry trends or competitive landscape for INSMED Inc.

Comparison to Industry Standards

• This filing is a disclosure of beneficial ownership and does not contain information suitable for comparison to industry standards, specific comparable companies, projects, or results.

Stakeholder Impact

• Shareholders: Increased institutional ownership may be perceived positively, potentially signaling confidence in the company's value.
• Company Management: Awareness of a significant passive shareholder, though without intent to influence control.

Next Steps

• The Reporting Persons will be required to file amendments to this Schedule 13G if there are material changes to their beneficial ownership or if their intent changes from passive to active.

Key Dates

Keywords

INSMED Inc., Common Stock, Schedule 13G, Beneficial Ownership, Darwin Global Management, Dr. Abhishek Trehan, Institutional Investor, Passive Investment, SEC Filing